Jean-Pierre Bedos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jean-Pierre Bedos has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Benoit Misset
Intensive Care Department and Burn Centre, University Hospital of Liège, University of Liège, 4000 Liège, Belgium
6 shared publications - Bruno Mégarbane
Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris Cité University, Paris, France
4 shared publications F Bruneel
4 shared publications- François Philippart
Medical and Surgical Intensive Care Department, Groupe Hospitalier Paris Saint Joseph, Paris, France
4 shared publications - Rémy Gauzit
Cochin University of Science and Technology
4 shared publications - Stephane Legriel
Médecine Intensive Réanimation, Centre Hospitalier de Versailles - Site André Mignot, 177 rue de Versailles, Le Chesnay cedex, 78150, France; IctalGroup, Le Chesnay, France; Université Paris-Saclay, Université de Versailles Saint Quentin enYvelines, Villejuif, 94807, France
4 shared publications
Latest Publications
- Open Access
- 24 October 2021
- Published by Elsevier in Annals of Intensive Care
- Vol. 11 (1) , 1-10
Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study
- 24 October 2021
- Published by Elsevier in Annals of Intensive Care
- Vol. 11 (1) , 1-10
Open AccessComparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study
- 1 June 2021
- Published by Elsevier in Infectious Diseases Now
- Vol. 51 (4) , 383-386
Invasive Aspergillosis associated with Covid-19: A word of caution
- 1 June 2021
- Published by Elsevier in Infectious Diseases Now
- Vol. 51 (4) , 383-386
Invasive Aspergillosis associated with Covid-19: A word of caution
- 19 November 2018
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (12) , 2162-2173
Host–pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study
To assess the relative importance of host and bacterial factors associated with hospital mortality in patients admitted to the intensive care unit (ICU) for pneumococcal community-acquired pneumonia (PCAP).
- 19 November 2018
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (12) , 2162-2173
Host–pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study
To assess the relative importance of host and bacterial factors associated with hospital mortality in patients admitted to the intensive care unit (ICU) for pneumococcal community-acquired pneumonia (PCAP).
- 1 February 2018
- Published by Elsevier in Journal of Critical Care
- Vol. 43, 375-377
Prior antimicrobial therapy duration influences causative pathogens identification in ventilator-associated pneumonia
- 1 February 2018
- Published by Elsevier in Journal of Critical Care
- Vol. 43, 375-377
Prior antimicrobial therapy duration influences causative pathogens identification in ventilator-associated pneumonia
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A19-A20
Peut-on traiter les patients, avec comorbidités, hospitalisés pour pneumonies communautaires par 3jours de bétalactamines ?
- 1 January 2017
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 34, A19-A20
Peut-on traiter les patients, avec comorbidités, hospitalisés pour pneumonies communautaires par 3jours de bétalactamines ?
- Open Access
- 1 January 2016
- Published by Elsevier in Annals of Intensive Care
- Vol. 6 (1) , 54-10
Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS
- 1 January 2016
- Published by Elsevier in Annals of Intensive Care
- Vol. 6 (1) , 54-10
Open AccessNeuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS
- 3 June 2015
- Published by Springer Nature in Intensive Care Medicine
- Vol. 41 (7) , 1181-1196
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)
Emerging resistance to antibiotics shows no signs of decline. At the same time, few new antibacterials are being discovered. There is a worldwide recognition regarding the danger of this situation. The urgency of the situation and the conviction that practices should change led the Société de Réanimation de Langue Française (SRLF) and the Société Française d’Anesthésie et de Réanimation (SFAR) to set up a panel of experts from various disciplines. These experts met for the first time at the end of 2012 and have since met regularly to issue the following 67 recommendations, according to the rigorous GRADE methodology. Five fields were explored: i) the link between the resistance of bacteria and the use of antibiotics in intensive care; ii) which microbiological data and how to use them to reduce antibiotic consumption; iii) how should antibiotic therapy be chosen to limit consumption of antibiotics; iv) how can antibiotic administration be optimized; v) review and duration of antibiotic treatments. In each institution, the appropriation of these recommendations should arouse multidisciplinary discussions resulting in better knowledge of local epidemiology, rate of antibiotic use, and finally protocols for improving the stewardship of antibiotics. These efforts should contribute to limit the emergence of resistant bacteria.
- 3 June 2015
- Published by Springer Nature in Intensive Care Medicine
- Vol. 41 (7) , 1181-1196
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)
Emerging resistance to antibiotics shows no signs of decline. At the same time, few new antibacterials are being discovered. There is a worldwide recognition regarding the danger of this situation. The urgency of the situation and the conviction that practices should change led the Société de Réanimation de Langue Française (SRLF) and the Société Française d’Anesthésie et de Réanimation (SFAR) to set up a panel of experts from various disciplines. These experts met for the first time at the end of 2012 and have since met regularly to issue the following 67 recommendations, according to the rigorous GRADE methodology. Five fields were explored: i) the link between the resistance of bacteria and the use of antibiotics in intensive care; ii) which microbiological data and how to use them to reduce antibiotic consumption; iii) how should antibiotic therapy be chosen to limit consumption of antibiotics; iv) how can antibiotic administration be optimized; v) review and duration of antibiotic treatments. In each institution, the appropriation of these recommendations should arouse multidisciplinary discussions resulting in better knowledge of local epidemiology, rate of antibiotic use, and finally protocols for improving the stewardship of antibiotics. These efforts should contribute to limit the emergence of resistant bacteria.
- 11 September 2014
- Published by Lavoisier in Réanimation
- Vol. 23 (5) , 558-582
Stratégies de réduction de l’utilisation des antibiotiques à visée curative en réanimation (adulte et pédiatrique)
- 11 September 2014
- Published by Lavoisier in Réanimation
- Vol. 23 (5) , 558-582
Stratégies de réduction de l’utilisation des antibiotiques à visée curative en réanimation (adulte et pédiatrique)
- Open Access
- 29 May 2014
- Published by Springer Nature in Intensive Care Medicine
- Vol. 40 (7) , 988-997
Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting
Purpose This prospective observational study aimed at describing prescription patterns of tigecycline and patient outcomes in 26 French intensive care units (ICU). Methods Data of consecutive cases of adult patients treated with tigecycline were collected from the initiation until 7 days after the end of treatment. Response to treatment was classified as success, failure or undetermined and analyses were presented according to severity (SOFA score P < 0.001). Success rate was 65 % for patients alive at the end of treatment. Success rates tended to decrease with illness severity, immunosuppression, bacteraemia and obesity. Survival rate at day 28 was 85 % in the whole cohort and significantly higher in the less severely ill patients (P < 0.001). Conclusions Tigecycline success rates appear comparable to those reported in clinical studies in ICU with severe infections. Tigecycline could be an alternative in ICU patients.
- 29 May 2014
- Published by Springer Nature in Intensive Care Medicine
- Vol. 40 (7) , 988-997
Open AccessTigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting
Purpose This prospective observational study aimed at describing prescription patterns of tigecycline and patient outcomes in 26 French intensive care units (ICU). Methods Data of consecutive cases of adult patients treated with tigecycline were collected from the initiation until 7 days after the end of treatment. Response to treatment was classified as success, failure or undetermined and analyses were presented according to severity (SOFA score P < 0.001). Success rate was 65 % for patients alive at the end of treatment. Success rates tended to decrease with illness severity, immunosuppression, bacteraemia and obesity. Survival rate at day 28 was 85 % in the whole cohort and significantly higher in the less severely ill patients (P < 0.001). Conclusions Tigecycline success rates appear comparable to those reported in clinical studies in ICU with severe infections. Tigecycline could be an alternative in ICU patients.
- 25 February 2014
- Published by Springer Nature in Neurocritical Care
- Vol. 20 (3) , 494-501
Artery of Percheron Infarction as an Unusual Cause of Coma: Three Cases and Literature Review
Stroke due to occlusion of the artery of Percheron (AOP), an uncommon anatomic variant supplying the bilateral medial thalami, may raise diagnostic challenges and cause life-threatening symptoms. Our objective here was to detail the features and outcomes in three patients who required intensive care unit (ICU) admission and to review the relevant literature. Description of three cases and literature review based on a 1973–2013 PubMed search. Three patients were admitted to our ICU with sudden-onset coma and respiratory and cardiovascular dysfunctions requiring endotracheal mechanical ventilation. Focal neurological deficits, ophthalmological signs (abnormal light reflexes and/or ocular motility and/or ptosis), and neuropsychological abnormalities were variably combined. Initial CT scan was normal. Cerebral MRI demonstrated bilateral paramedian thalamic infarction, with extension to the cerebral peduncles in two patients. Consciousness improved rapidly and time to extubation was 1–4 days. All three patients were discharged alive from the hospital and two had good 1-year functional outcomes. Similar clinical features and outcomes were recorded in the 117 patients identified in the literature, of whom ten required ICU admission. Bilateral paramedian thalamic stroke due to AOP occlusion can be life threatening. The early diagnosis relies on MRI with magnetic resonance angiography. Recovery of consciousness is usually rapid and mortality is low, warranting full-code ICU management.
- 25 February 2014
- Published by Springer Nature in Neurocritical Care
- Vol. 20 (3) , 494-501
Artery of Percheron Infarction as an Unusual Cause of Coma: Three Cases and Literature Review
Stroke due to occlusion of the artery of Percheron (AOP), an uncommon anatomic variant supplying the bilateral medial thalami, may raise diagnostic challenges and cause life-threatening symptoms. Our objective here was to detail the features and outcomes in three patients who required intensive care unit (ICU) admission and to review the relevant literature. Description of three cases and literature review based on a 1973–2013 PubMed search. Three patients were admitted to our ICU with sudden-onset coma and respiratory and cardiovascular dysfunctions requiring endotracheal mechanical ventilation. Focal neurological deficits, ophthalmological signs (abnormal light reflexes and/or ocular motility and/or ptosis), and neuropsychological abnormalities were variably combined. Initial CT scan was normal. Cerebral MRI demonstrated bilateral paramedian thalamic infarction, with extension to the cerebral peduncles in two patients. Consciousness improved rapidly and time to extubation was 1–4 days. All three patients were discharged alive from the hospital and two had good 1-year functional outcomes. Similar clinical features and outcomes were recorded in the 117 patients identified in the literature, of whom ten required ICU admission. Bilateral paramedian thalamic stroke due to AOP occlusion can be life threatening. The early diagnosis relies on MRI with magnetic resonance angiography. Recovery of consciousness is usually rapid and mortality is low, warranting full-code ICU management.